Palazestrant matching placebo tablets and Letrozole matching placebo capsules, Palazestrant, RIBOCICLIB, Palazestrant, -, LETROZOLE , Palazestrant
OP-1250-302
Phase 3 small_molecule active
Quick answer
Palazestrant matching placebo tablets and Letrozole matching placebo capsules, Palazestrant, RIBOCICLIB, Palazestrant, -, LETROZOLE , Palazestrant for ER+, HER2- Advanced Breast Cancer is a Phase 3 program (small_molecule) at Olema Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Olema Pharmaceuticals
- Indication
- ER+, HER2- Advanced Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active